<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-673
Date of Submission: 2025-04-08

This report was submitted by a Pharmacist from Scott-Wagner Medical Center concerning patient ANON-PX-7276. The subject is a 78-year-old male with a significant medical history including coronary artery disease, chronic kidney disease, asthma, type 2 diabetes. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril (ACE inhibitor) administered via the Intramuscular route at a dosage of 8mg, initiated on 2025-02-11 for Hypertension with the course ongoing.

On approximately 2025-04-02, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Vomiting, Stevens-Johnson syndrome. The Dizziness was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed identify and advised car. The current patient status regarding this symptom is 'Recovering'. The Vomiting was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Stevens-Johnson syndrome was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed car and advised help. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2025-673
report_date: '2025-04-08'
patient_details:
  patient_id: ANON-PX-7276
  gender: Male
  relevant_history:
  - coronary artery disease
  - chronic kidney disease
  - asthma
  - type 2 diabetes
  age_at_reaction: 78
suspected_drugs:
- drug_name: Lisinopril
  dosage: 8mg
  route_of_administration: Intramuscular
  start_date: '2025-02-11'
  indication_for_use: Hypertension
  drug_class: ACE inhibitor
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2025-04-02'
  severity: Mild
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed identify and advised car.
- symptom_name: Vomiting
  onset_date: '2025-04-02'
  severity: Mild
  outcome: Unknown
  intervention_required: false
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-04-02'
  severity: Mild
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed car and advised help.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 8
reporting_facility: Scott-Wagner Medical Center
reporter_type: Pharmacist
